Aclaris Therapeutics, Inc. Shares Outstanding
Aclaris Therapeutics, Inc. (ACRS) had Shares Outstanding of 139.82 million shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Prices
us-gaap:CommonStockSharesOutstanding · last filed 2026-08-06
- 2026-06-30: Shares outstanding (split-adjusted) 139.82M shares; Shares authorized (split-adjusted) 400.00M shares.
- 2026-03-31: Shares outstanding (split-adjusted) 139.65M shares; Shares authorized (split-adjusted) 400.00M shares.
- 2025-12-31: Shares outstanding (split-adjusted) 120.50M shares; Shares authorized (split-adjusted) 400.00M shares.
- 2025-09-30: Shares outstanding (split-adjusted) 108.34M shares; Shares authorized (split-adjusted) 400.00M shares.
| Period end | Shares outstanding (split-adjusted) | Shares authorized (split-adjusted) |
|---|---|---|
| 2026-06-30 | 139.82M shares 10-Q · filed 2026-08-06 | 400.00M shares 10-Q · filed 2026-08-06 |
| 2026-03-31 | 139.65M shares 10-Q · filed 2026-05-07 | 400.00M shares 10-Q · filed 2026-05-07 |
| 2025-12-31 | 120.50M shares 10-Q · filed 2026-08-06 | 400.00M shares 10-Q · filed 2026-08-06 |
| 2025-09-30 | 108.34M shares 10-Q · filed 2025-11-06 | 400.00M shares 10-Q · filed 2025-11-06 |
| 2025-06-30 | 108.33M shares 10-Q · filed 2025-08-07 | 400.00M shares 10-Q · filed 2025-08-07 |
| 2025-06-05 | (m) | 400.00M shares 10-K · filed 2026-02-26 |
| 2025-06-04 | (m) | 200.00M shares 10-K · filed 2026-02-26 |
| 2025-03-31 | 108.27M shares 10-Q · filed 2025-05-08 | 200.00M shares 10-Q · filed 2025-05-08 |
| 2024-12-31 | 107.85M shares 10-K · filed 2026-02-26 | 200.00M shares 10-K · filed 2026-02-26 |
| 2024-09-30 | 71.42M shares 10-Q · filed 2024-11-06 | 200.00M shares 10-Q · filed 2024-11-06 |
| 2024-06-30 | 71.33M shares 10-Q · filed 2024-08-07 | 200.00M shares 10-Q · filed 2024-08-07 |
| 2024-03-31 | 71.25M shares 10-Q · filed 2024-05-07 | 200.00M shares 10-Q · filed 2024-05-07 |
| 2023-12-31 | 70.89M shares 10-K · filed 2025-02-27 | 200.00M shares 10-K · filed 2025-02-27 |
| 2023-09-30 | 70.82M shares 10-Q · filed 2023-11-06 | 200.00M shares 10-Q · filed 2023-11-06 |
| 2023-06-30 | 70.77M shares 10-Q · filed 2023-08-07 | 200.00M shares 10-Q · filed 2023-08-07 |
| 2023-06-01 | (m) | 200.00M shares 10-K · filed 2024-02-27 |
| 2023-05-31 | (m) | 100.00M shares 10-K · filed 2024-02-27 |
| 2023-03-31 | 67.21M shares 10-Q · filed 2023-05-08 | 100.00M shares 10-Q · filed 2023-05-08 |
| 2022-12-31 | 66.69M shares 10-K · filed 2024-02-27 | 100.00M shares 10-K · filed 2024-02-27 |
| 2022-09-30 | 66.68M shares 10-Q · filed 2022-11-08 | 100.00M shares 10-Q · filed 2022-11-08 |
| 2022-06-30 | 66.67M shares 10-Q · filed 2022-08-03 | 100.00M shares 10-Q · filed 2022-08-03 |
| 2022-03-31 | 61.74M shares 10-Q · filed 2022-05-10 | 100.00M shares 10-Q · filed 2022-05-10 |
| 2021-12-31 | 61.23M shares 10-K · filed 2023-02-23 | 100.00M shares 10-K · filed 2023-02-23 |
| 2021-09-30 | 61.23M shares 10-Q · filed 2021-11-02 | 100.00M shares 10-Q · filed 2021-11-02 |
| 2021-06-30 | 61.20M shares 10-Q · filed 2021-08-05 | 100.00M shares 10-Q · filed 2021-08-05 |
| 2021-03-31 | 52.08M shares 10-Q · filed 2021-05-07 | 100.00M shares 10-Q · filed 2021-05-07 |
| 2020-12-31 | 45.11M shares 10-K · filed 2022-02-24 | 100.00M shares 10-K · filed 2022-02-24 |
| 2020-09-30 | 42.92M shares 10-Q · filed 2020-11-04 | 100.00M shares 10-Q · filed 2020-11-04 |
| 2020-06-30 | 42.69M shares 10-Q · filed 2020-08-07 | 100.00M shares 10-Q · filed 2020-08-07 |
| 2020-03-31 | 41.83M shares 10-Q · filed 2020-05-07 | 100.00M shares 10-Q · filed 2020-05-07 |
| 2019-12-31 | 41.49M shares 10-K · filed 2021-02-25 | 100.00M shares 10-K · filed 2021-02-25 |
| 2019-09-30 | 41.38M shares 10-Q · filed 2019-11-07 | 100.00M shares 10-Q · filed 2019-11-07 |
| 2019-06-30 | 41.28M shares 10-Q · filed 2019-08-08 | 100.00M shares 10-Q · filed 2019-08-08 |
| 2019-03-31 | 41.27M shares 10-Q · filed 2019-05-08 | 100.00M shares 10-Q · filed 2019-05-08 |
| 2018-12-31 | 41.21M shares 10-K · filed 2020-02-25 | 100.00M shares 10-K · filed 2020-02-25 |
| 2018-09-30 | 30.99M shares 10-Q · filed 2018-11-06 | 100.00M shares 10-Q · filed 2018-11-06 |
| 2018-06-30 | 30.97M shares 10-Q · filed 2018-08-03 | 100.00M shares 10-Q · filed 2018-08-03 |
| 2018-03-31 | 30.91M shares 10-Q · filed 2018-05-08 | 100.00M shares 10-Q · filed 2018-05-08 |
| 2017-12-31 | 30.86M shares 10-K · filed 2019-03-18 | 100.00M shares 10-K · filed 2019-03-18 |
| 2017-09-30 | 30.83M shares 10-Q · filed 2017-11-07 | 100.00M shares 10-Q · filed 2017-11-07 |
| 2017-06-30 | 26.74M shares 10-Q · filed 2017-08-08 | 100.00M shares 10-Q · filed 2017-08-08 |
| 2017-03-31 | 26.10M shares 10-Q · filed 2017-05-09 | 100.00M shares 10-Q · filed 2017-05-09 |
| 2016-12-31 | 26.06M shares 10-K · filed 2018-03-12 | 100.00M shares 10-K · filed 2018-03-12 |
| 2016-09-30 | 21.42M shares 10-Q · filed 2016-11-03 | 100.00M shares 10-Q · filed 2016-11-03 |
| 2016-06-30 | 21.40M shares 10-Q · filed 2016-08-11 | 100.00M shares 10-Q · filed 2016-08-11 |
| 2016-03-31 | 20.32M shares 10-Q · filed 2016-05-11 | 100.00M shares 10-Q · filed 2016-05-11 |
| 2015-12-31 | 20.16M shares 10-K · filed 2017-03-15 | 100.00M shares 10-K · filed 2017-03-15 |
| 2015-09-30 | 2.73M shares 10-Q · filed 2015-12-03 | 110.00M shares 10-Q · filed 2015-12-03 |
| 2014-12-31 | 2.73M shares 10-K · filed 2016-03-23 | 77.00M shares 10-K · filed 2016-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |